Skip to content

VNS-supplemented Motor Retraining After Stroke

Mechanisms of Non-invasive Vagus Nerve Stimulation Underlying Enhanced Motor Control in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04088578
Enrollment
26
Registered
2019-09-13
Start date
2019-09-22
Completion date
2021-11-09
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

The goal of this study is to learn more about the connections between the brain, spinal cord, and muscles and how these connections can be strengthened after neurological injury.

Detailed description

To establish a link between the physiological mechanisms driving enhanced motor control in response to VNS, subjects will undergo progressive training on a visuomotor task that requires fine gradation of voluntary motor output to control a moving object through target boundaries. In separate groups, VNS or sham stimulation will be paired with movement when a minimal time-on-target (ToT) is achieved.

Interventions

OTHERTraining

Controlling movement of an object on computer screen by adjusting muscle activity.

OTHERVagus Nerve Stimulation

Recruits the auricular branch of the vagus nerve which activates brain structures that release chemicals mediating cortical plasticity.

OTHERSham Stimulation

Sub-threshold stimulation that does not activate neural structures.

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

INDIVIDUALS WHO HAVE HAD A STROKE: 1. Diagnosis of first ever stroke 2. At least 6 months after stroke onset 3. Motor-evoked potentials in hand/arm muscles 4. Subjects must show an understanding of the study goals and have the ability to follow simple directions as judged by the investigators. ALL INDIVIDUALS: 5. Between the ages of 18 and 75 years old

Exclusion criteria

INDIVIDUALS WHO HAVE HAD A STROKE: 1. Hemispatial neglect, aphasia, or cognitive impairment that would impact testing and would interfere with the ability to follow simple instructions, as judged by the investigators ALL INDIVIDUALS: 2. Neurological disorder(s) influencing movement (besides stroke) 3. History of seizure or epilepsy 4. Metallic brain implants 5. Bodily implants such as cardioverter defibrillators, insulin pumps, ventriculoperitoneal shunts, cochlear implants, or pacemakers 6. Pregnant or expecting to become pregnant 7. Difficulty maintaining alertness and/or remaining still 8. Silicone or plastic allergy 9. History of vestibular disorders (eg, Vertigo, Meniere's Disease, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Change in time-on-target score.3 weeksThe score reflects the total time the object overlaps any part of targets, expressed as a percentage (0-100) of the total possible time. Thus, a score of 0 is the worst possible score, whereas, 100 is the best possible score. The primary endpoint is the change from baseline (ie, before training) in the time-on-target score.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026